Balyasny Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Buy |
971,414
+589,707
| +154% | +$10.7M | 0.03% | 539 |
|
|
2025
Q1 | $7.57M | Buy |
+381,707
| New | +$7.57M | 0.01% | 744 |
|
|
2024
Q4 | – | Sell |
-446,388
| Closed | -$8.92M | – | 1882 |
|
|
2024
Q3 | $8.92M | Sell |
446,388
-1,048,351
| -70% | -$21M | 0.01% | 710 |
|
|
2024
Q2 | $16.7M | Buy |
1,494,739
+1,435,397
| +2,419% | +$16M | 0.03% | 503 |
|
|
2024
Q1 | $392K | Buy |
59,342
+27,131
| +84% | +$179K | ﹤0.01% | 1562 |
|
|
2023
Q4 | $146K | Buy |
+32,211
| New | +$146K | ﹤0.01% | 1785 |
|
|
2022
Q2 | – | Sell |
-143,115
| Closed | -$262K | – | 2246 |
|
|
2022
Q1 | $262K | Buy |
+143,115
| New | +$262K | ﹤0.01% | 1612 |
|